ArticleJournal of neuromuscular diseases2021

Safety Monitoring of Gene Therapy for Spinal Muscular Atrophy with Onasemnogene Abeparvovec -A Single Centre Experience.

Johannes Friese et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.